Key facts
| Recalling firm | Johnson & Johnson Surgical Vision, Inc. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | FUSION Dual Pump Packs, REF: OPO73 |
| Classification | Class II |
| Recall number | Z-1006-2023 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of FUSION Dual Pump Packs, REF: OPO73 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Johnson & Johnson Surgical Vision, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Johnson & Johnson Surgical Vision, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Johnson & Johnson Surgical Vision, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Johnson & Johnson Surgical Vision, Inc.’s FDA history
Argus HQ has recorded 8 total FDA actions tied to Johnson & Johnson Surgical Vision, Inc.: 0 warning letters, 8 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Why was FUSION Dual Pump Packs, REF: OPO73 recalled?
- FDA's recall record states the reason as: Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.
- Who should I contact about this recall?
- Contact Johnson & Johnson Surgical Vision, Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
- Has Johnson & Johnson Surgical Vision, Inc. had other FDA recalls or enforcement actions?
- Yes. Argus HQ has recorded 8 total FDA actions tied to Johnson & Johnson Surgical Vision, Inc., including 8 recalls and 0 warning letters.
- What is the FDA recall number for this event?
- FDA recall number Z-1006-2023.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Johnson & Johnson Surgical Vision, Inc.- Recall: Johnson & Johnson Surgical Vision, Inc. — Class II recall: Johnson & Johnson VISION Reusable LAMINAR High Flow Irrigation Sleeve and Test C… →
- Recall: Johnson & Johnson Surgical Vision, Inc. — Class II recall: TECNIS Toric II OptiBlue IOL Models ZCW →
- Recall: Johnson & Johnson Surgical Vision, Inc. — Class II recall: TECNIS Eyhance IOL, REF: ICB00, STERILE.EO, Rx Only →
- Recall: Johnson & Johnson Surgical Vision, Inc. — Class II recall: TECNIS Symfony, Extended Range of Vision IOL, REF: ZXR00, STERILE.EO, Rx Only →
- Recall: Johnson & Johnson Surgical Vision, Inc. — Class II recall: VERITAS Advanced Infusion Packs (VRT-AI) and VERITAS Advanced Fluidics Packs (VR… →
- Recall: Johnson & Johnson Surgical Vision, Inc. — Class II recall: Veritas Advanced Infusion Packs, REF: VRT-AI →
- Recall: Johnson & Johnson Surgical Vision, Inc. — Class II recall: Single-Use Packs, REF: OPO80 →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2023). Recall Record: Class II Recall: FUSION Dual Pump Packs, REF: OPO73 by Johnson & Johnson Surgical Vision, Inc.. Digital Empire LLC. Retrieved from https://argushq.ai/recall/johnson-and-johnson-surgical-vision-z-1006-2023-2023-02-01
"Recall Record: Class II Recall: FUSION Dual Pump Packs, REF: OPO73 by Johnson & Johnson Surgical Vision, Inc.." Argus HQ Research, Digital Empire LLC, 2023, argushq.ai/recall/johnson-and-johnson-surgical-vision-z-1006-2023-2023-02-01.
Argus HQ Research. "Recall Record: Class II Recall: FUSION Dual Pump Packs, REF: OPO73 by Johnson & Johnson Surgical Vision, Inc.." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/johnson-and-johnson-surgical-vision-z-1006-2023-2023-02-01.
@misc{argushq_argushq_ai_recall_johnson_and_johnson_surgical_vision_z_1006_2023_2023_02_01_2023,
title = {Recall Record: Class II Recall: FUSION Dual Pump Packs, REF: OPO73 by Johnson & Johnson Surgical Vision, Inc.},
author = {{Argus HQ Research}},
year = {2023},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/johnson-and-johnson-surgical-vision-z-1006-2023-2023-02-01},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗

